Clinical trial
A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in…
NCT00250445 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00250445 |
|---|---|
| Title | A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066) |
| Official title | A Randomized, Double-Blind, Active-Comparator-Controlled, Parallel-Group Study to Evaluate the Safety of Etoricoxib in Patients With Osteoarthritis or Rheumatoid Arthritis |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis, Osteoarthritis |
| Intervention type | Drug |
| Interventions | MK0663, etoricoxib, Comparator: Diclofenac sodium |
| Enrollment | 23,498 |
| Start date | Jan 1, 2003 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Nov 8, 2005 |
| Last update posted | Feb 18, 2022 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: